Paysign Q3 revenue $7.8M; plasma $7.0M (+35.6% YoY); net loss $0.3M; raises adj. EBITDA guidance to $1.3-1.9M

Paysign, Inc.

2021-Q3 EPS reported -$0.06 revenue$20,697,907

Total revenue $7.8M for Q3 2021, up $1.1M (16.8%) from Q2 2021 and $7.9M from year-ago.
Plasma revenue $7.0M (+35.6% YoY); added 3 plasma centers for a total of 359.
Net loss of $0.3M ($0.01 per diluted share) compared to net loss of $6.2M in Q3 2020.
Adjusted EBITDA $1.0M ($0.02 per share) vs. $0.3M loss a year ago; FY forecast raised to $1.3-1.9M.
Gross profit margin guidance raised 250 bps to 49.0% for full year 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.